Canadian Tire Cuts 6% Of Full Time Positions While Announcing $200 Million In Buybacks
Canadian Tire Corporation (TSX: CTC) reported today that it will be cutting full-time staff by 3% via targeted headcount reductions, while cutting the majority of current job vacancies as well, resulting in total headcount reductions of 6% of full time equivalent roles. The cuts are expected to result in annual run-rate savings of $50.0 million […]
Trulieve Sees Q3 Revenues Fall Slightly To $275 Million, Cash Flow Improves
Trulieve Cannabis (CSE: TRUL) reported a mixed bag of results this morning for its third quarter. The company saw its revenue decline a slight 2% from the second quarter to $275 million, while substantially narrowing its net loss. Gross profit for the quarter amounted to $143 million, improving gross margins by two percentage points over […]
Disney Exceeds Q4 2023 Earnings Expectations Amidst Streaming Success
Disney (NYSE: DIS) exceeded expectations in its recent earnings report, with notable contributions from ESPN+ profitability and continued expansion in theme park revenue. However, a decline in advertising revenue had a dampening effect on the overall financial performance. To address the challenges, Disney announced an increase in cost-cutting measures by an additional $2 billion, aiming […]
Hollywood Actors Reach Tentative Deal, Ending 118-Day Strike
Hollywood actors have reached a tentative agreement with major studios to end the 118-day work stoppage that had disrupted the entertainment industry. The Screen Actors Guild‐American Federation of Television and Radio Artists (SAG-AFTRA) union announced the resolution following unanimous support from its negotiating committee. The strike began in mid-July, with actors demanding higher minimum salaries, […]
Embattled Realtor Association Is Also the Top-Spending Lobbying Group in the US in 2022
The National Association of Realtors (NAR), with 1.5 million members, is known for being the largest professional organization in the United States, and it is also, by far, the top-spending lobbying group in the entire country. In 2020 and 2022, NAR outspent all other organizations in the country and maintained second place in lobbying expenditures […]
NDP’s Rachel Notley Alleges Conservatives Want To “Rip Apart” Healthcare In Alberta
Rachel Notley, the Leader of the Alberta NDP, revealed on X (fka Twitter) that her party will be sharing a mysterious set of documents she claims to have received in the mail. These 35 pages of documents allegedly detail a plan by the United Conservative Party (UCP) to significantly transform the healthcare system in Alberta, […]
F3 Uranium Drops $217k On 3% Interest In Private Jet
What’s the sense in working so much if you can’t enjoy the spoils of your troubles? That’s what F3 Uranium’s (TSXV: FUU) management appears to have asked themselves when earlier this year they spent company funds to “invest” in a stake in a private jet, which investors are just now learning about. The company made […]
King Charles Reads A Speech About Easing the Cost of Living While Wearing A Diamond-Encrusted Crown
The world is burning. It was perhaps more surreal — or just sillier — than ever to watch a monarch talk about easing the cost of living while sitting on a gilded throne and wearing a golden crown encrusted by 2,868 diamonds. But one can take a bit of comfort in knowing King Charles, the […]
MrBeast Gets ‘Canceled’ for Helping Provide Clean Drinking Water to Africa
American YouTuber MrBeast, also known as Jimmy Donaldson, has released a video featuring his initiative to build 100 wells across Africa, and not surprisingly, it drew a mixed response from online audiences. The video, published on Saturday, showcases Donaldson’s efforts to provide clean drinking water to over 500,000 people in Cameroon, Kenya, Somalia, Uganda, and […]
AstraZeneca, GSK, Teva All On FTC’s Notice Due To “Improperly Listed” Patents
The U.S. Federal Trade Commission (FTC) issued letters to various medical device companies and drugmakers, including AbbVie, AstraZeneca, and subsidiaries of Glaxo-Smith Kline and Teva, raising concerns about the accuracy and relevance of 110 patents, which could potentially lead to delays in generic competition. The patents in question, many of which are listed in the […]